Literature DB >> 2465018

Quantitation of autoantibodies to cytokeratins in sera from patients with squamous cell carcinoma of the oesophagus.

R B Veale1, A L Thornley, E Scott, A Antoni, I Segal.   

Abstract

Sera drawn from healthy individuals, patients with squamous cell carcinoma (SCC) of the oesophagus and patients with mild active oesophagitis were examined for autoantibodies to cytoskeletal proteins extracted from the normal oesophageal keratinocyte or from 2 carcinoma cell lines, each of the latter have a simple cytoskeleton. Using a radioimmunoassay with normal oesophageal cytokeratins as bound antigen, 86 normal, 76 SCC and 14 oesophagitis sera were compared. No significant difference in autoantibody titre was found. When the bound antigen was changed to one containing predominantly simple epithelial cytokeratins a significant increase (32% P less than 0.001) was noted in the SCC category only. Western blots using simple epithelial cell extracts as antigen revealed autoantibodies to cytokeratins 8, 18 and 19 as well as to one other unidentified protein in most SCC sera, and in some normal sera. Antibodies to cytokeratin 18 predominated. Normal and SCC sera were applied using indirect immunofluorescent techniques to normal oesophageal keratinocytes, SNO oesophageal SCC cells and HeLa cells grown in vitro. Autoantibodies to oesophageal cytokeratins were, with few exceptions, barely detectable. Strong reactions were noted against SNO and HeLa cytoskeletal components, but also against nuclear membrane and nucleolar determinants. These experiments suggest that raised levels of autoantibodies to certain cytoskeletal and nuclear determinants may be a feature of oesophageal cancer.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2465018      PMCID: PMC2246860          DOI: 10.1038/bjc.1988.305

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  34 in total

1.  Antibodies to the cytoskeleton components and other autoantibodies in inflammatory bowel disease.

Authors:  D Zauli; C Crespi; P Dall'Amore; F B Bianchi; E Pisi
Journal:  Digestion       Date:  1985       Impact factor: 3.216

2.  Keratin expression in normal esophageal epithelium and squamous cell carcinoma of the esophagus.

Authors:  M P Grace; K H Kim; L D True; E Fuchs
Journal:  Cancer Res       Date:  1985-02       Impact factor: 12.701

Review 3.  The detection of human antibodies against cytoskeletal components.

Authors:  P Kurki; I Virtanen
Journal:  J Immunol Methods       Date:  1984-03-16       Impact factor: 2.303

4.  Antibodies to vimentin intermediate filaments in sera from patients with SLE and RA: quantitation by solid phase radioimmunoassay.

Authors:  A Alcover; F Ramirez-Lafita; C Hernandez; A Nieto; J Avila
Journal:  J Rheumatol       Date:  1985-04       Impact factor: 4.666

5.  Anticytoskeletal autoantibodies in the connective tissue diseases.

Authors:  J L Senécal; J M Oliver; N Rothfield
Journal:  Arthritis Rheum       Date:  1985-08

6.  Complex cytokeratin polypeptide patterns observed in certain human carcinomas.

Authors:  R Moll; R Krepler; W W Franke
Journal:  Differentiation       Date:  1983       Impact factor: 3.880

7.  Antibodies to cytoplasmic intermediate filaments in rheumatic diseases.

Authors:  P Kurki; T Helve; I Virtanen
Journal:  J Rheumatol       Date:  1983-08       Impact factor: 4.666

8.  Diagnostic value of antikeratin antibodies in rheumatoid arthritis.

Authors:  J Ordeig; J Guardia
Journal:  J Rheumatol       Date:  1984-10       Impact factor: 4.666

9.  Tissue polypeptide antigen (TPA) is related to the non-epidermal keratins 8, 18 and 19 typical of simple and non-squamous epithelia: re-evaluation of a human tumor marker.

Authors:  K Weber; M Osborn; R Moll; B Wiklund; B Lüning
Journal:  EMBO J       Date:  1984-11       Impact factor: 11.598

10.  Purification of the 300K intermediate filament-associated protein and its in vitro recombination with intermediate filaments.

Authors:  N Lieska; H Y Yang; R D Goldman
Journal:  J Cell Biol       Date:  1985-09       Impact factor: 10.539

View more
  3 in total

1.  Characterisation of the rat oesophagus epithelium antigens defined by the so-called 'antikeratin antibodies', specific for rheumatoid arthritis.

Authors:  E Girbal; M Sebbag; V Gomès-Daudrix; M Simon; C Vincent; G Serre
Journal:  Ann Rheum Dis       Date:  1993-10       Impact factor: 19.103

Review 2.  Serum autoantibodies in the early detection of esophageal cancer: a systematic review.

Authors:  Hongfei Zhang; Junfen Xia; Kaijuan Wang; Jianying Zhang
Journal:  Tumour Biol       Date:  2014-11-30

3.  Prognostic relevance of Bmi-1 expression and autoantibodies in esophageal squamous cell carcinoma.

Authors:  Wan-li Liu; Xian-zhi Guo; Lan-jun Zhang; Jun-ye Wang; Ge Zhang; Su Guan; Yu-min Chen; Qing-li Kong; Li-hua Xu; Man-zhi Li; Li-bing Song; Mu-sheng Zeng
Journal:  BMC Cancer       Date:  2010-09-01       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.